Podcast

How to Use Digital Cognitive Testing Tools to Aid in the Diagnosis of Mild Cognitive Impairment (MCI) and Dementia

Launch Date
06/14/2021
Credit Amount
0.00 Expired
Credit Expires
06/14/2021

Faculty

Kathleen Rogers, MD
Chief of Service, Geriatric Medicine, Cleveland Clinic Akron General. Stow, OH
Kathleen Rogers, MD

Dr. Rogers serves as the Chair of Geriatrics at the Cleveland Clinic, Akron General. She completed her MD at Case Western Reserve University, residency at St. Vincent’s Hospital Center, and fellowship at The MetroHealth System in Cleveland, Ohio. Dr. Rogers is board certified in internal medicine and geriatric medicine and serves as teaching faculty for NEOMED, Case Western Reserve University, St. Vincent Charity Hospital Internal Medicine Residency Program, and Cleveland Clinic Akron General Internal Medicine Residency Program.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Additional Formats

Statement of Need

Mild cognitive impairment (MCI) is a condition in which individuals demonstrate focal or multifocal impairment with minimal impairment of instrumental activities of daily living (IADL) that does not cross the threshold for dementia diagnosis. It can be the first cognitive expression Alzheimer’s disease (AD) or secondary to other disease processes that can cause cognitive deficits. Early diagnosis and intervention can help reduce the burden of AD; however, there are many challenges in diagnosing MCI, including difficulty differentiating it from normal aging, comorbidities offering “alternative diagnoses,”, fear, ageism, and lack of awareness by the patient/family.

This CME Outfitters podcast focuses on integrating cognitive testing into annual wellness visits for adults in order to identify cognitive impairment early to initiate referral to a specialist, and on integrating digital cognitive assessments into clinical workflow and remotely to differentiate normal aging from preclinical cognitive decline.

Learning Objectives

At the end of this CME/CE activity, participants should be able to integrate digital cognitive testing tools into clinical workflow to aid in the diagnosis of MCI and dementia.

Financial Support

Supported by an educational grant from BrainCheck.

Target Audience

Primary care physicians, neurologists, psychiatrists, and nurse practitioners.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

ABPN MOC

ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Rogers has no disclosures to report.

  • Susan Perry (planning committee) has no disclosures to report.
  • Jan Perez (planning committee) has no disclosures to report.
  • Sharon Tordoff (planning committee) has no disclosures to report.
  • Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-21-062-H02-P.

 

PD-069-061421-70

How to Use Digital Cognitive Testing Tools to Aid in the Diagnosis of Mild Cognitive Impairment (MCI) and Dementia
Event Date: 06/14/2021